Journal: SM Musculoskeletal Disorders PDF
Published: Mar 14, 2019 Volume: 4 Issue: 1 Pages: 1-5
DOI: 10.19080/jpfmts.2019.06.555680 ISSN: 2576-5442
Authors: Mahendra Kumar Trivedi and Snehasis Jana
Citation: Trivedi MK and Jana S. Impact of Biofield Energy Healing Treatment: Evaluation of Anti-Rheumatoid Activity Using Synovial Sarcoma Cell Line (SW982). SM Musculoskelet Disord. 2019; 4(1): 1034.
- 55 Views
- 5 Downloads
The present research was performed to monitor the anti-rheumatoid action of Consciousness Energy Healing based DMEM medium using synovial sarcoma cell line, SW982. The study included the evaluation of bone health potential using inflammatory parameter, IL-8. The test item (DMEM medium) was divided into three parts, first part received a one-time Consciousness Energy Healing Treatment by a renowned Biofield Energy Healer, Mahendra Kumar Trivedi and was labeled as the one-time Biofield Energy Treated (BT-I) DMEM, while second part received the two-times the Biofield Energy Treatment and is denoted as BT-II DMEM. The third part did not receive any treatment and defined as the untreated DMEM group. Cell viability assay using MTT method showed that the cell viability of SW982 cells was 113.8% and 88.3% in the BT-I and BT-II groups, respectively. The BT-I group demonstrated significant (p≤0.001) inhibition of IL-8 by 27.74%, while BT-II group also showed a significant (p≤0.001) inhibition of IL-8 by 45.66% as compared to the untreated DMEM group. In conclusion, the data suggested that the Consciousness Energy Healing Treatment significantly inhibited the pro-inflammatory cytokine (IL-8) that showed anti-rheumatic action and can also be used in other bone and inflammatory disorders such as osteoporosis, Paget’s disease of bone, rickets, deformed bones, osteomalacia, osteoma, stress, aging, bone loss, and fractures along with autoimmune disorders and overall quality of life.
The anti-RA activity was tested for Biofield Energy Healing based DMEM using SW982 cells and the results demonstrated significant benefits with respect to the inflammatory cytokine inhibition (IL-8). SW982 cells were used for cell viability and the results showed significant increase in cell viability with 113.8% and 88.3% in the BT-I and BT-II groups, respectively, as compared with the control group. The effect of the test samples demonstrated a significant (p≤0.001) inhibition of IL-8level by 27.74% in the one-time Biofield Energy Treated DMEM (BT-I) group and 45.66% in two-times Biofield Energy Treated (BT-II) group as compared to the untreated DMEM group in SW982 cells. Thus, the present experiment showed that the Biofield Energy Treated (The Trivedi Effect®) DMEM has significant impact to improve RA disease pathology, which could also improve the overall bone health. MTT data showed that Biofield Energy Treatment improved the growth of SW982 cells. Therefore, the Consciousness Energy Healing based DMEM might be suitable as an alternative media for cell growth. Besides, Biofield Energy Healing Treatment can be used to manage the RA and its associated bone-related disorders viz. rickets, deformed bones, osteoporosis, osteomalacia, Paget’s disease, bone and/or joint pain, stress, aging, osteoma, hormonal imbalance, bone loss and fractures, and other bone diseases due to poor nutrition, genetics, or problems with the reduced bone growth or rebuilding. Besides, The Trivedi Effect® could also be useful against immune-related disease like Dermatitis, Pernicious Anemia, Aplastic Anemia, Ulcerative Colitis, Graves’Disease, Irritable Bowel Syndrome, Alzheimer’s disease, Multiple Sclerosis, Hepatitis, Dermatomyositis, Diabetes, Myasthenia Gravis, Parkinson’s disease, Atherosclerosis, and many more with a safe therapeutic index.